Introduction:

Arch aortic disease, especially with age, arteriosclerosis and other factors, more and more patients suffer from aortic arch disease. This type of lesion is often difficult to operate due to its special location, which brings great challenges to the treatment of patients. Traditional surgical procedures, while effective in some cases, are not available to many high-risk patients due to their high risk and complexity. With the advancement of medical technology, hybrid technology, as an emerging treatment method, has gradually become a breakthrough means for the treatment of arch aortic lesions.

Combining the advantages of traditional open surgery and modern interventional therapy, hybrid technology has shown remarkable results in the treatment of arch aortic lesions. Through interventional surgery to implant vascular stents without complete thoracotomy and surgical repair of the lesion area, hybrid technology maintains a high level of treatment effect while reducing the surgical trauma of patients. Compared with traditional surgery, the application of hybrid technology greatly reduces the incidence of postoperative complications and significantly shortens the length of hospital stay for patients.

Specifically, hybridization begins with the implantation of a stent at the lesion site of the aorta through interventional treatment to ensure that blood flow returns to normal in the lesion area. This procedure is carried out with the help of imaging equipment, which greatly improves the accuracy of the treatment. The surgeon then performs minimally invasive surgery to repair other relevant lesion areas. This approach not only preserves the stability of the treatment effect, but also reduces the patient's trauma and recovery period.

In addition, the hybrid technique is particularly useful for patients who are too old to withstand traditional surgery due to old age or serious underlying medical conditions. For example, hybrid technology provides a new treatment avenue for some elderly patients or patients with heart disease or diabetes who are unable to undergo open surgery due to difficulties in postoperative recovery.

With the continuous development of technology, the application of hybridization technology in the treatment of other types of aortic lesions has gradually expanded. From the initial arch aortic lesion to other complex aortic diseases, hybridization technology has been gradually introduced into clinical practice and has shown very good prospects.

As a revolutionary method for the treatment of arch aortic lesions, hybridization technology has achieved remarkable clinical results. As the technology continues to mature, it is expected to further reduce the difficulty and cost of treatment in the future, making it suitable for more patients. With the deepening of global medical cooperation, hybridization technology is expected to become one of the standardized treatment options for the treatment of arch aortic lesions worldwide.